E-LIB Suche - Ergebnisse für: Rajagovindan, R.

1

Iluzanebart Phase 2, IGNITE Study: First Interventional Stu..:

Lynch, D. ; Gelfand, J. ; Kumar, R....
Parkinsonism & Related Disorders. 122 (2024) - p. 106139 , 2024

Link: https://doi.org/10.1016/..

2

Investigating Partially Discordant Results in Phase 3 Studi..:

Mallinckrodt, C. ; Tian, Y. ; Aisen, P.S....
The Journal Of Prevention of Alzheimer's Disease. , 2023

Link: https://doi.org/10.14283..

3

Ignite, a phase 2 proof-of-concept study of VGL101 in patie..:

Gelfand, J. ; Meier, A. ; Rajagovindan, R....
Neuroscience Applied. 2 (2023) - p. 102483 , 2023

Link: https://doi.org/10.1016/..

4

Two Randomized Phase 3 Studies of Aducanumab in Early Alzhe..:

Budd Haeberlein, S. ; Aisen, P.S. ; Barkhof, F....
The Journal of Prevention of Alzheimer's Disease. , 2022

Link: https://doi.org/10.14283..

5

Gabapentin‐induced pharmacodynamic effects in the spinal ne..:

Hooker, B.A. ; Tobon, G. ; Baker, S.J....
European Journal of Pain. 18 (2013) 2 - p. 223-237 , 2013

Link: https://doi.org/10.1002/..

6

Investigating Partially Discordant Results in Phase 3 Studi..:

Mallinckrodt, C ; Tian, Y ; Aisen, PS...
https://discovery.ucl.ac.uk/id/eprint/10163690/1/jpad.2023.6.pdf. , 2023

Link: https://discovery.ucl.ac..

7

Two Randomized Phase 3 Studies of Aducanumab in Early Alzhe..:

Budd Haeberlein, S ; Aisen, PS ; Barkhof, F...
https://discovery.ucl.ac.uk/id/eprint/10146033/1/BuddHaeberlein2022_Article_TwoRandomizedPhase3StudiesOfAd.pdf. , 2022

Link: https://discovery.ucl.ac..

8

Prevalence of Chronic Kidney Disease and Its Determinants i..:

Kumar P, Ravi ; Dongre, Amol ; Muruganandham, R...
The Open Urology & Nephrology Journal. 12 (2019) 1 - p. 14-22 , 2019

Link: https://doi.org/10.2174/..